ASP Isotopes Inc. Form 8-K Summary
Reporting date: December 4, 2023; filed December 5, 2023. The filing reports voting results from the company’s 2023 Annual Meeting of Stockholders. It does not provide operating or financial results for the period.
Business Context and Reporting Period
ASP Isotopes Inc. is a Delaware corporation whose common stock trades on Nasdaq under the symbol ASPI. The company is an emerging growth company. The Annual Meeting was held on December 4, 2023, and covered two proposals described in the company’s November 2, 2023 definitive proxy statement.
Financial and Other Key Metrics
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, cash balances, or other operating financial metrics.
| Metric | Result |
|---|---|
| Common stock outstanding voting results | Proposal-specific totals are reported below; the filing does not state the total shares outstanding. |
| Independent auditor | EisnerAmper LLP was ratified for the fiscal year ending December 31, 2023. |
Material Changes Versus Prior Period
No material operating, financial, capital structure, or liquidity changes versus a prior comparable period are disclosed.
Governance, Outlook, Risks, and Unusual Items
- Director elections: Class I directors Paul Mann and Joshua Donfeld were elected to serve until the 2026 annual meeting or until their successors are elected and qualified.
- Paul Mann: 18,699,866 votes for, 46,160 withheld, and 4,531,159 broker non-votes.
- Joshua Donfeld: 18,588,449 votes for, 157,577 withheld, and 4,531,159 broker non-votes.
- Auditor ratification: EisnerAmper LLP was ratified with 23,225,300 votes for, 27,328 against, and 24,557 abstentions.
- The filing contains no management guidance, business outlook, contingency disclosures, or new risk-factor discussion.
Important Facts for Investors to Verify
- Confirm the directors’ continued service and committee assignments following the Annual Meeting.
- Review the November 2, 2023 proxy statement for director qualifications, governance matters, and the basis for auditor ratification.
- Review subsequent SEC filings for financial results, financing activity, liquidity requirements, and any developments affecting the company’s business outlook.